Drug maker Rohto plans clinical trials in Hong Kong as OASES’ first Japan partner

South China Morning Post - Nov 2, 2026

Top university research, cross-border data exchanges and access to mainland China’s large market have attracted Japanese firm Rohto Pharmaceutical to conduct clinical trials in Hong Kong, making it the first company from the country to partner with the city’s government under a flagship investment initiative. Rohto, known for its over-the-counter eye care and skincare products, is among the latest batch of 18 firms recruited by the Office for Attracting Strategic Enterprises (OASES), a...

Read full article

More News

Asia Viral News

Asia Viral News features the latest and most trending news from Asia. Get ready to immerse yourself in the daily engaging topics with share-worthy news only in Asia Viral News.

Newsletter